Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
mice) shows improved efficacy (regression) in a 92
InChiKey: SETFNECMODOHTO-UHFFFAOYSA-N
with no discernible correction in the absence of exogenous zeitgebers in rats
most notably the subdermal implant Nexplanon and the vaginal ring NuvaRing
as well as in vivo
ABT-333 Catalog No.:M9232-2 mice) shows improved efficacy (regression)Dasabuvir, also known as ABT 333, is a non nucleoside polymerase inhibitor currently under clinical trials for the treatment of Hepatitis C. In the United States, it is approved by the Food and Drug Administration for use in combination with ombitasvir, paritaprevir, and ritonavir in the product Viekira Pak. Dasabuvir acts as a NS5B (an RNA directed RNA polymerase) inhibitor. Product information CAS Number: 1132935 63 7 Molecular Weight: 493. 57
US$ 119.00
US$ 16.50
US$ 127.50
US$ 14.95
US$ 169.00
US$ 164.00
US$ 184.50
US$ 155.00